Sammaan Capital posts ₹8,101.41 crore Q4 consolidated loss; audited FY26 results
Sammaan Capital · Finance
Key highlights
- Consolidated loss attributable to shareholders for the quarter ended March 31, 2026 is ₹(8,101.41) crore, against a profit of ₹324.04 crore in the year-earlier quarter.
- Exceptional item of ₹6,499.17 crore and other comprehensive loss of ₹652.78 crore relate to reclassification and sale of Identified Exposures to an ARC.
- FY26 cash flows show ₹4,560.96 crore from equity share issues and ₹1,065.75 crore application money against share warrants.
Why it's rated major development: the year-on-year change is 100% (20% or more for adverse news)
Figures checked against the filing by a second AI read, which corrected the first summary. About the business, not the share price.
Original filing
Audited Standalone And Consolidated Financial Results Of The Company, For The Quarter And Financial Year Ended March 31, 2026.
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
More from Sammaan Capital
- Fundraise / allotmentNotableSammaan Capital allots 8.69 crore shares on conversion of Tranche I Warrants to promoter
- Fundraise / allotmentNotableSammaan Capital allots NCDs of INR 500 Crore and INR 275 Crore on private placement
- Acquisition / mergerNotableSammaan Capital holds NCLT-directed shareholder meeting on demerger scheme with SFL
- Acquisition / mergerNotableSammaan Capital Limited shareholders approve scheme of arrangement on Sep 10, 2026
- Fundraise / allotmentNotableSammaan Capital Limited Board Approves Fundraising and Director Changes
Other financial results filings this fortnight
- Siddhika Coatings Limited approves joint venture and announces H1 FY 2026 financials
- Financial resultsBrooks LaboratoriesBrooks Laboratories Limited announces Q2 and H1 FY2026 unaudited financial results
- Financial resultsBrooks LaboratoriesBrooks Laboratories Limited announces Q2 and H1 FY2027 financial results and divestment
- NHC Foods reports Sept 2026 quarter results, 99.98% firm stake, two appointments
- Spectrum Electrical Industries Ltd approves Q2 & H1 results for period ended September 30, 2026
- Dev Labtech Venture reports unaudited half-year results to 30 Sept 2026
Potential multibaggers · Q2 FY27
Potential multibaggers in Finance
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.